CVS Investors Have the Opportunity to Join CVS Health Corporation, Inc. Securities Fraud Investigation with the Schall Law Firm
LOS ANGELES, July 16, 2024 /PRNewswire/ -- The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of CVS Health Corporation ("CVS" or "the Company") (NYSE: CVS) for violations of the securities laws.
The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors. CVS announced its first quarter results missing Wall Street expectations and revised down its 2024 guidance. The Company now expects earnings per share of $7 as opposed to previous estimates of $8.30. Mizuho healthcare expert Jared Holz wrote in a note to clients, "Did not even believe the CVS numbers when they were released and anticipate a great deal of pressure on shares given the magnitude of this negative financial revision." Based on this news, shares of CVS fell by more than 17.7% on May 1, 2024.
If you are a shareholder who suffered a loss, click here to participate.
We also encourage you to contact Brian Schall of the Schall Law Firm, 2049 Century Park East, Suite 2460, Los Angeles, CA 90067, at 310-301-3335, to discuss your rights free of charge. You can also reach us through the firm's website at www.schallfirm.com, or by email at [email protected].
The Schall Law Firm represents investors around the world and specializes in securities class action lawsuits and shareholder rights litigation.
This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics.
CONTACT:
The Schall Law Firm
Brian Schall, Esq.
310-301-3335
[email protected]
www.schallfirm.com
SOURCE The Schall Law Firm
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?
Newsrooms &
Influencers
Digital Media
Outlets
Journalists
Opted In
Share this article